Haemonetics (HAE)
(Real Time Quote from BATS)
$84.84 USD
-1.01 (-1.18%)
Updated Jun 11, 2024 12:18 PM ET
1-Strong Buy of 5 1
C Value C Growth F Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
HAE 84.84 -1.01(-1.18%)
Will HAE be a Portfolio Killer in June?
Zacks Investment Research is releasing its prediction for HAE based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HAE
Best Momentum Stocks to Buy for June 6th
New Strong Buy Stocks for June 6th
HAE: What are Zacks experts saying now?
Zacks Private Portfolio Services
These 3 Companies Boast Bright Outlooks
Best Momentum Stocks to Buy for June 4th
Why Haemonetics (HAE) is a Top Growth Stock for the Long-Term
Other News for HAE
These 3 Companies Boast Bright Outlooks
Insider Sale: President of Global Hospital at Haemonetics Corp (HAE) Sells Shares
Insider Sale: EVP and General Counsel Michelle Basil Sells 12,990 Shares of Haemonetics Corp (HAE)
HAE Crosses Below Key Moving Average Level
Haemonetics Prices Upsized Private Placement of $600 Million Convertible Senior Notes